Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Shares Issued (2018 - 2025)

vTv Therapeutics' Shares Issued history spans 7 years, with the latest figure at -$9000.0 for Q4 2025.

  • For Q4 2025, Shares Issued rose 99.63% year-over-year to -$9000.0; the TTM value through Dec 2025 reached -$9000.0, changed N/A, while the annual FY2021 figure was $47000.0, 99.67% down from the prior year.
  • Shares Issued for Q4 2025 was -$9000.0 at vTv Therapeutics, up from -$2.5 million in the prior quarter.
  • Across five years, Shares Issued topped out at $26.1 million in Q3 2021 and bottomed at -$26.1 million in Q4 2021.
  • The 4-year median for Shares Issued is -$1.2 million (2024), against an average of -$625250.0.
  • The largest YoY upside for Shares Issued was 963.4% in 2021 against a maximum downside of 655.14% in 2021.
  • A 4-year view of Shares Issued shows it stood at -$26.1 million in 2021, then surged by 80.66% to -$5.0 million in 2022, then surged by 51.13% to -$2.5 million in 2024, then soared by 99.63% to -$9000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Shares Issued are -$9000.0 (Q4 2025), -$2.5 million (Q4 2024), and $2.5 million (Q3 2024).